世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ヘルスケアにおける量子コンピューティング市場：コンポーネント（ハードウェア、ソフトウェア）、デプロイメント（オンプレミス、クラウドベース）、技術（超伝導量子ビット、トラップイオン）、アプリケーション（創薬、ゲノミクス）、エンドユーザー、地域別 - 2028年までの世界予測


Quantum Computing in Healthcare Market by Component (Hardware, Software), Deployment (0n-premises, Cloud-based), Technology (Superconducting qubits, Trapped ions), Application (Drug discovery, Genomics), End User, and Region - Global Forecast to 2028

ヘルスケアにおける量子コンピューティングの世界市場は、予測期間中に42.5％の高いCAGRで、2023年の8500万米ドルから2028年には503百万米ドルに達すると予測されます。様々なヘルスケアアプリケーションをサポー... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 図表数 言語
MarketsandMarkets
マーケッツアンドマーケッツ 		2023年5月15日 US$4,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		210 171 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

ヘルスケアにおける量子コンピューティングの世界市場は、予測期間中に42.5％の高いCAGRで、2023年の8500万米ドルから2028年には503百万米ドルに達すると予測されます。様々なヘルスケアアプリケーションをサポートする量子コンピューティングの技術的進歩は、予測期間中、市場に有利な機会を提供します。

"ヘルスケア市場において、クラウドベースセグメントは予測期間中に最も高いCAGRを記録した、展開別 "
2022年、ヘルスケアにおける量子コンピューティング市場では、クラウドベースセグメントが大きなシェアを占めています。クラウドベースセグメントの成長は、急速に進歩している量子コンピューティングシステムの寿命が限られていること、手間のかからないスケーラビリティと柔軟性、ひいては量子クラウドサービスを使用しながら最終的な意思決定プロセスを改善することに起因していると考えられる。

"ヘルスケアにおける量子コンピューティング市場、技術別で超伝導キュービット部門が最大シェアを占める"
2022年、超伝導量子ビットセグメントはヘルスケアにおける量子コンピューティング市場で最大のシェアを占めました。この大きなシェアは、超伝導量子ビットに基づく量子コンピューティングシステムのゲート速度が速く、この種の量子ビットで高度な制御が可能なため、創薬、画像診断、個別化医療などのさまざまなアプリケーションに柔軟に使用できることに起因しているものと考えられる。

"2022年、ヘルスケア分野における量子コンピューティング市場のエンドユーザー別セグメントでは、製薬・バイオ医薬品企業が最大規模"
2022年、ヘルスケアにおける量子コンピューティング市場では、製薬・バイオ製薬会社セグメントが大きなシェアを占めています。製薬＆バイオ医薬品企業セグメントの成長は、量子コンピューティングが、標的の特定、薬剤設計、毒性試験を試行錯誤に依存しないようにすることで、研究開発を劇的に速く、より的を絞って正確に行うことができるため、複雑な創薬＆開発手順の迅速化や、精度の強化につながることに起因すると考えられる。また、長期的には、資源や資本の有効活用、投資対効果の向上、慢性疾患に対する新薬の提供の大幅な増加などのメリットが期待できます。

"予測期間中、APACが最も高い成長率を目撃する"
アジア太平洋地域は、予測期間中に最も高いCAGRで成長すると予測されています。研究＆ゲノミクス目的での量子コンピューティングなどの先端技術への需要の高まり、新興地域での量子コンピューティングへの認識と導入の高まり、医療インフラの改善などの要因が挙げられます。
主な参加企業の内訳は、以下の通りです：
- 企業タイプ別：Tier1：45％、Tier2：30％、Tier3：25％。
- 役職別：Cレベル：42％、ディレクターレベル：31％、その他：27
- 地域別：北米32％、欧州32％、アジア太平洋26％、中東・アフリカ5％、中南米5％。

ヘルスケア分野における量子コンピューティング市場の主要企業
ヘルスケアにおける量子コンピューティング市場で事業を展開する主なプレーヤーは、IBM（米国）、Google社（米国）、Rigetti & Co, LLC.(米国）、Quandela（フランス）、D-Wave Quantum Inc.（カナダ）、Quantinuum, Ltd. （米国・英国）、ID Quantium, Inc.(米国・英国）、ID Quantique（スイス）、Zapata Computing（米国）、Atos SE（フランス）、IonQ（米国）、Classiq Technologies, Inc（米国）、Xanadu Quantum Technologies Inc（カナダ）、QC Ware（カリフォルニア）、Protiviti Inc（米国）、 Hefei Origin Quantum Computing Technology Co.(中国）、PwC（英国）、Deloitte（英国）、Accenture（アイルランド）、Amazon Web Services（米国）、Pasqal（フランス）、富士通（日本）、Sandbox AQ（米国）、SEEQC（米国）、Quintessence Labs（オーストラリア）、Qnami（スイス）です。
調査範囲です：
当レポートでは、ヘルスケアにおける量子コンピューティング市場を分析し、コンポーネント、展開モード、アプリケーション、テクノロジー、エンドユーザー、地域に基づいて、様々な市場セグメントの市場規模および将来の成長可能性を推定することを目的としています。また、本市場で事業を展開する主要企業の競争分析も行い、企業プロフィール、製品提供、最近の開発状況、主要な市場戦略も併せて掲載しています。
本レポートを購入する理由
本レポートは、既存企業だけでなく、新規参入企業や小規模企業も市場の動向を把握するのに役立ち、ひいては市場シェアを拡大するのに役立つと思われます。本レポートを購入された企業は、以下の戦略の1つまたは複数を組み合わせて、市場でのポジションを強化することができます。
本レポートは、以下のような洞察を提供します：
 主要な促進要因（先進国および新興国における量子コンピューティングへの投資の増加、支払者の量子コンピューティングへの傾斜の高まり、個別化医療への需要の高まり、量子コンピューティング新興企業への資金調達と投資の増加）、阻害要因（量子コンピューティングシステムの精度問題、高い導入コスト）、機会（様々なヘルスケアアプリケーションを支える量子コンピュータの技術進歩、医療画像解析や腫瘍学への応用の可能性）、ヘルスケア相互接続ソリューション市場の成長に影響を及ぼす課題（専門技術不足とデータ管理問題）についての分析。
 製品開発/イノベーション：ヘルスケアにおける量子コンピューティング市場における今後の技術、研究開発活動、新製品・サービス投入に関する詳細なインサイトを提供します。
 市場開発：有利な新興市場、コンポーネント、展開モード、技術、アプリケーション、エンドユーザー、地域に関する包括的な情報。
 市場の多様化：製品ポートフォリオ、成長する地域、最近の開発、ヘルスケアにおける量子コンピューティング市場への投資に関する詳細な情報
 競争力評価：IBM（米国）、Google（米国）、Rigetti & Co, LLC（米国）、Quandela（米国）など、ヘルスケア分野における量子コンピューティング市場の主要企業の市場シェア、成長戦略、製品提供、能力を詳細に評価。(米国）、Quandela（フランス）、D-Wave Quantum Inc.（カナダ）、Quantinuum, Ltd. （米国・英国）などです。(米国・英国)があります。

ページTOPに戻る


目次

1 INTRODUCTION 27
1.1 STUDY OBJECTIVES 27
1.2 MARKET DEFINITION 27
TABLE 1 INCLUSIONS & EXCLUSIONS 27
1.3 STUDY SCOPE 28
1.3.1 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY REGION 28
1.3.2 YEARS CONSIDERED 29
1.4 CURRENCY CONSIDERED 29
TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 29
1.5 STAKEHOLDERS 30
1.6 LIMITATIONS 30
1.7 IMPACT OF RECESSION 30
2 RESEARCH METHODOLOGY 31
2.1 RESEARCH APPROACH 31
FIGURE 1 RESEARCH DESIGN 31
2.1.1 SECONDARY RESEARCH 32
2.1.1.1 Key data from secondary sources 33
2.1.2 PRIMARY RESEARCH 33
2.1.2.1 Primary sources 34
2.1.2.2 Key data from primary sources 35
2.1.2.3 Breakdown of primaries 35
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 35
2.1.2.4 Insights from primary experts 36
2.2 MARKET SIZE ESTIMATION 36
FIGURE 3 BOTTOM-UP APPROACH 37
FIGURE 4 TOP-DOWN APPROACH 37
FIGURE 5 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF QUANTUM COMPUTING IN HEALTHCARE INDUSTRY 39
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 39
2.3 MARKET BREAKDOWN DATA TRIANGULATION 41
FIGURE 7 DATA TRIANGULATION METHODOLOGY 41
2.4 MARKET SHARE ESTIMATION 41
2.5 STUDY ASSUMPTIONS 42
2.6 RESEARCH LIMITATIONS 42
2.6.1 METHODOLOGY-RELATED LIMITATIONS 42
2.7 RISK ASSESSMENT 43
TABLE 3 RISK ASSESSMENT: QUANTUM COMPUTING IN HEALTHCARE MARKET 43
2.8 IMPACT OF RECESSION ON QUANTUM COMPUTING IN HEALTHCARE MARKET 43
3 EXECUTIVE SUMMARY 44
FIGURE 8 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023 VS. 2028 (USD MILLION) 44
FIGURE 9 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023 VS. 2028 (USD MILLION) 45
FIGURE 10 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 45
FIGURE 11 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 46
FIGURE 12 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 46
FIGURE 13 QUANTUM COMPUTING IN HEALTHCARE MARKET: REGIONAL SNAPSHOT 47
4 PREMIUM INSIGHTS 48
4.1 OVERVIEW OF QUANTUM COMPUTING IN HEALTHCARE MARKET 48
FIGURE 14 GOVERNMENT SUPPORT FOR ADOPTION OF QUANTUM COMPUTING TO DRIVE MARKET GROWTH 48
4.2 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT 49
FIGURE 15 HARDWARE SEGMENT AND JAPAN TO COMMAND LARGEST SHARES OF ASIA PACIFIC MARKET IN 2022 49
4.3 GEOGRAPHIC SNAPSHOT OF QUANTUM COMPUTING IN HEALTHCARE MARKET 50
FIGURE 16 MARKET IN CHINA TO GROW AT HIGHEST CAGR 50
4.4 REGIONAL MIX: QUANTUM COMPUTING IN HEALTHCARE MARKET 51
FIGURE 17 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
FIGURE 18 QUANTUM COMPUTING IN HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 52
TABLE 4 MARKET DYNAMICS: QUANTUM COMPUTING IN HEALTHCARE MARKET 53
5.2.1 MARKET DRIVERS 53
5.2.1.1 Increasing investments in quantum computing in developed as well as emerging economies 53
5.2.1.2 Growing inclination of payers toward quantum computing 54
5.2.1.3 Rising demand for personalized medicine 54
5.2.1.4 Increasing funding and investments in quantum computing startups 55
5.2.2 RESTRAINTS 56
5.2.2.1 Accuracy issues with quantum computing systems and high implementation costs 56
5.2.3 OPPORTUNITIES 56
5.2.3.1 Technological advancements in quantum computing supporting various healthcare applications 56
5.2.3.2 Potential applications in medical image analysis and oncology 57
5.2.4 CHALLENGES 57
5.2.4.1 Lack of technical expertise and data management issues 57
6 INDUSTRY INSIGHTS 58
6.1 INDUSTRY TRENDS 58
6.1.1 HYBRID QUANTUM-CLASSICAL COMPUTING 58
6.1.2 QUANTUM MACHINE LEARNING 59
6.1.3 GROWING NUMBER OF APPLICATIONS IN HEALTHCARE INDUSTRY 59
6.2 TECHNOLOGY ANALYSIS 60
6.2.1 QUANTUM ARTIFICIAL INTELLIGENCE 60
6.2.2 QUANTUM COMMUNICATION TECHNOLOGY 60
6.2.3 QUANTUM COMPUTING ACADEMIA 61
6.2.4 CYBERSECURITY TRANSFORMATION 61
6.2.5 QUANTUM SENSING 61
6.3 PORTER’S FIVE FORCES ANALYSIS 61
FIGURE 19 QUANTUM COMPUTING MARKET: PORTER’S FIVE FORCES ANALYSIS 62
6.4 REGULATORY ANALYSIS 62
6.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63
TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63
TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64
TABLE 8 ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64
6.4.2 REGULATORY STANDARDS 65
6.4.2.1 P1913 – Software-defined quantum communication 65
6.4.2.2 P7130 – Standard for quantum technologies definitions 65
6.4.2.3 P7131 – Standard for quantum computing performance metrics and benchmarking 65
6.5 VALUE CHAIN ANALYSIS 65
FIGURE 20 QUANTUM COMPUTING IN HEALTHCARE MARKET: VALUE CHAIN ANALYSIS 65
6.5.1 RESEARCH, DESIGN, AND DEVELOPMENT 66
6.5.2 MANUFACTURERS & SERVICE PROVIDERS 66
6.5.3 MARKETING & SALES EXECUTIVES 66
6.5.4 END USERS 66
6.6 ECOSYSTEM ANALYSIS 66
FIGURE 21 QUANTUM COMPUTING IN HEALTHCARE MARKET: ECOSYSTEM ANALYSIS 67
6.7 PATENT ANALYSIS 67
FIGURE 22 TOP PATENT OWNERS AND APPLICANTS FOR HEALTHCARE IT SOLUTIONS (JANUARY 2011–APRIL 2023) 68
FIGURE 23 PATENT ANALYSIS: QUANTUM COMPUTING IN HEALTHCARE MARKET (JANUARY 2015–APRIL 2023) 68
6.8 CASE STUDY ANALYSIS 69
TABLE 9 MENTEN AI LEVERAGED D-WAVE QUANTUM COMPUTING PRODUCTS TO BATTLE COVID-19 WITH QUANTUM PEPTIDE THERAPEUTICS 69
6.9 KEY STAKEHOLDERS AND BUYING CRITERIA 70
6.9.1 KEY STAKEHOLDERS ON BUYING PROCESS 70
FIGURE 24 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS 70
TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 70
6.9.2 BUYING CRITERIA 71
FIGURE 25 KEY BUYING CRITERIA FOR QUANTUM COMPUTING BY COMPONENTS 71
TABLE 11 KEY BUYING CRITERIA FOR QUANTUM COMPUTING BY COMPONENT 71
6.10 KEY CONFERENCES AND EVENTS (2023–2024) 72
6.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 73
FIGURE 26 REVENUE SHIFT IN QUANTUM COMPUTING IN HEALTHCARE MARKET 73
7 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT 74
7.1 INTRODUCTION 75
TABLE 12 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 75
7.2 SOFTWARE 75
7.2.1 SHIFT TO WEB/CLOUD-BASED MODELS TO SUPPORT GROWTH 75
TABLE 13 QUANTUM COMPUTING IN HEALTHCARE SOFTWARE OFFERED BY KEY MARKET PLAYERS 76
TABLE 14 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION) 76
7.3 HARDWARE 77
7.3.1 NEED FOR FREQUENT HARDWARE UPGRADES TO DRIVE MARKET GROWTH 77
TABLE 15 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION) 77
7.4 SERVICES 78
7.4.1 INTRODUCTION OF COMPLEX SOFTWARE TO DRIVE DEMAND FOR SERVICES 78
TABLE 16 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 79
8 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT 80
8.1 INTRODUCTION 81
TABLE 17 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 81
8.2 ON-PREMISES 81
8.2.1 RISING DEPLOYMENT OF ON-PREMISES QUANTUM COMPUTERS BY ORGANIZATIONS TO ENSURE DATA SECURITY 81
TABLE 18 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR ON-PREMISES SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION) 82
8.3 CLOUD-BASED 82
8.3.1 INCREASING PREFERENCE FOR CLOUD-BASED QUANTUM COMPUTING FOR RESEARCH & DEVELOPMENT USING DIFFERENT APPROACHES 82
TABLE 19 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR CLOUD-BASED SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION) 83
9 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY 84
9.1 INTRODUCTION 85
TABLE 20 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 85
9.2 SUPERCONDUCTING QUBITS 85
9.2.1 LOW POWER CONSUMPTION, HIGH SPEED, AND ABILITY TO OPERATE AT LOW TEMPERATURES TO DRIVE MARKET 85
TABLE 21 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR SUPERCONDUCTING QUBITS, BY COUNTRY, 2021–2028 (USD MILLION) 86
9.3 TRAPPED IONS 86
9.3.1 SUPERIOR CONNECTIVITY AND HIGHER GATE FIDELITY TO DRIVE MARKET 86
TABLE 22 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR TRAPPED IONS, BY COUNTRY, 2021–2028 (USD MILLION) 87
9.4 QUANTUM ANNEALING 87
9.4.1 QUICK DISCOVERY OF MOST EFFICIENT CONFIGURATIONS AMONG POSSIBLE COMBINATIONS OF VARIABLES TO DRIVE MARKET 87
TABLE 23 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR QUANTUM ANNEALING, BY COUNTRY, 2021–2028 (USD MILLION) 88
9.5 OTHERS 88
TABLE 24 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 89
10 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION 90
10.1 INTRODUCTION 91
TABLE 25 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 91
10.2 DRUG DISCOVERY & DEVELOPMENT 91
10.2.1 ENABLING ACCURATE DATA PROJECTIONS AND SOLUTIONS FOR DRUG DISCOVERY AND DEVELOPMENT TO BOOST MARKET GROWTH 91
TABLE 26 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 92
10.3 MEDICAL DIAGNOSTICS 92
10.3.1 PRECISE AND SENSITIVE MEDICAL DIAGNOSTICS PROCEDURES TO DRIVE MARKET 92
TABLE 27 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR MEDICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 93
10.4 GENOMICS & PRECISION MEDICINE 93
10.4.1 UNLOCKING POWER OF GENOMICS & PRECISION MEDICINE WITH QUANTUM COMPUTING TECHNOLOGY 93
TABLE 28 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR GENOMICS & PRECISION MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 94
10.5 RADIOTHERAPY 94
10.5.1 QUANTUM RADIOTHERAPY: ENABLING MORE PERSONALIZED AND PRECISE TREATMENT IN FIGHT AGAINST CANCER 94
TABLE 29 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR RADIOTHERAPY, BY COUNTRY, 2021–2028 (USD MILLION) 95
10.6 RISK ANALYSIS 96
10.6.1 ENHANCES PRICING MODEL MANAGEMENT AND DECREASE IN COSTS ASSOCIATED WITH FRAUD 96
TABLE 30 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR RISK ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION) 96
10.7 OTHERS (POPULATION HEALTH MANAGEMENT, SECURITY IN HEALTHCARE) 97
10.7.1 SECURELY TRANSFORMING POPULATION HEALTH WITH QUANTUM COMPUTING 97
TABLE 31 QUANTUM COMPUTING IN HEALTHCARE MARKET OTHER APPLICATIONS (POPULATION HEALTH MANAGEMENT, SECURITY IN HEALTHCARE), BY COUNTRY, 2021–2028 (USD MILLION) 97
11 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY END USER 98
11.1 INTRODUCTION 99
TABLE 32 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 99
11.2 PHARMA & BIOPHARMA COMPANIES 99
11.2.1 RISING DEMAND FOR SOLUTIONS TO REDUCE TIME AND COSTS OF DRUG DEVELOPMENT 99
TABLE 33 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR PHARMA & BIOPHARMA COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 100
11.3 LABS & RESEARCH INSTITUTES 100
11.3.1 INCREASED RESEARCH ACTIVITIES TO ENCOURAGE USE OF AI IN GENOMICS IN ACADEMIC AND GOVERNMENT INSTITUTES 100
TABLE 34 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR LABS & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 101
11.4 HEALTHCARE PROVIDERS 101
11.4.1 HIGH NUMBER OF BENEFITS TO IMPROVE PATIENT MANAGEMENT, LOWER COSTS, AND DELIVER BETTER PATIENT TREATMENT 101
TABLE 35 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 102
11.5 HEALTHCARE PAYERS 102
11.5.1 POTENTIAL TO REDUCE READMISSIONS AND OVERHEAD COSTS TO DRIVE ADOPTION 102
TABLE 36 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 103
12 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY REGION 104
12.1 INTRODUCTION 105
TABLE 37 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY REGION, 2021–2028 (USD MILLION) 105
12.2 NORTH AMERICA 105
FIGURE 27 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET SNAPSHOT, 2022 106
TABLE 38 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 39 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 107
TABLE 40 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 107
TABLE 41 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 107
TABLE 42 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 108
TABLE 43 NORTH AMERICA: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 108
12.2.1 US 109
12.2.1.1 Expanding applications of quantum computing in healthcare to bolster market growth 109
TABLE 44 US: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 109
TABLE 45 US: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 109
TABLE 46 US: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 110
TABLE 47 US: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 110
TABLE 48 US: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 111
12.2.2 CANADA 111
12.2.2.1 Investments and developments in quantum computing industry to drive market 111
TABLE 49 CANADA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 112
TABLE 50 CANADA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 112
TABLE 51 CANADA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 112
TABLE 52 CANADA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 113
TABLE 53 CANADA: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 113
12.3 EUROPE 114
TABLE 54 EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 55 EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 115
TABLE 56 EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 115
TABLE 57 EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 115
TABLE 58 EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 116
TABLE 59 EUROPE: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 116
12.3.1 GERMANY 117
12.3.1.1 Collaborations & partnerships to drive adoption of quantum computing solutions 117
TABLE 60 GERMANY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 117
TABLE 61 GERMANY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 118
TABLE 62 GERMANY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 118
TABLE 63 GERMANY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 119
TABLE 64 GERMANY: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 119
12.3.2 UK 120
12.3.2.1 Increased focus on quantum computing applications to support growth 120
TABLE 65 UK: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 120
TABLE 66 UK: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 121
TABLE 67 UK: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 121
TABLE 68 UK: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 122
TABLE 69 UK: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 122
12.3.3 FRANCE 122
12.3.3.1 Government funding for quantum computing to bolster growth 122
TABLE 70 FRANCE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 123
TABLE 71 FRANCE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 123
TABLE 72 FRANCE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 124
TABLE 73 FRANCE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 124
TABLE 74 FRANCE: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 125
12.3.4 REST OF EUROPE 125
TABLE 75 REST OF EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 126
TABLE 76 REST OF EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 126
TABLE 77 REST OF EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 126
TABLE 78 REST OF EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 127
TABLE 79 REST OF EUROPE: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 127
12.4 ASIA PACIFIC 128
FIGURE 28 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE SNAPSHOT 129
TABLE 80 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 81 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 130
TABLE 82 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 130
TABLE 83 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 130
TABLE 84 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 131
TABLE 85 ASIA PACIFIC: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 131
12.4.1 JAPAN 132
12.4.1.1 Rising penetration of technologies to support market growth 132
TABLE 86 JAPAN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 132
TABLE 87 JAPAN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 133
TABLE 88 JAPAN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 133
TABLE 89 JAPAN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 134
TABLE 90 JAPAN: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 134
12.4.2 CHINA 134
12.4.2.1 Dominating healthcare market in Asia Pacific 134
TABLE 91 CHINA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 135
TABLE 92 CHINA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 135
TABLE 93 CHINA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 136
TABLE 94 CHINA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 136
TABLE 95 CHINA: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 137
12.4.3 REST OF ASIA PACIFIC 137
TABLE 96 REST OF ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 138
TABLE 97 REST OF ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 138
TABLE 98 REST OF ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 138
TABLE 99 REST OF ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 139
TABLE 100 REST OF ASIA PACIFIC: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 139
12.5 REST OF THE WORLD 140
TABLE 101 REST OF THE WORLD: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 140
TABLE 102 REST OF THE WORLD: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 141
TABLE 103 REST OF THE WORLD: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 141
TABLE 104 REST OF THE WORLD: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 142
TABLE 105 REST OF THE WORLD: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 142
13 COMPETITIVE LANDSCAPE 143
13.1 OVERVIEW 143
FIGURE 29 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2020 AND APRIL 2023 144
13.2 MARKET RANKING ANALYSIS 145
FIGURE 30 QUANTUM COMPUTING IN HEALTHCARE MARKET RANKING ANALYSIS, BY PLAYER, 2022 145
13.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 146
FIGURE 31 QUANTUM COMPUTING IN HEALTHCARE MARKET: REVENUE ANALYSIS OF KEY PLAYERS 146
13.4 QUANTUM COMPUTING IN HEALTHCARE MARKET: R&D EXPENDITURE 146
FIGURE 32 R&D EXPENDITURE OF KEY PLAYERS (2021 VS. 2022) 146
13.5 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 147
FIGURE 33 QUANTUM COMPUTING IN HEALTHCARE MARKET: GEOGRAPHIC REVENUE MIX 147
13.6 COMPETITIVE BENCHMARKING 148
TABLE 106 FOOTPRINTS OF COMPANIES IN QUANTUM COMPUTING IN HEALTHCARE MARKET 148
TABLE 107 COMPANY PRODUCT FOOTPRINT (26 COMPANIES) 149
TABLE 108 COMPANY APPLICATION FOOTPRINT (16 COMPANIES) 150
TABLE 109 COMPANY REGION FOOTPRINT (25 COMPANIES) 151
13.7 COMPANY EVALUATION QUADRANT 152
13.7.1 STARS 152
13.7.2 EMERGING LEADERS 152
13.7.3 PERVASIVE PLAYERS 152
13.7.4 PARTICIPANTS 153
FIGURE 34 QUANTUM COMPUTING IN HEALTHCARE MARKET: COMPANY EVALUATION QUADRANT (2022) 153
13.8 COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES 154
13.8.1 PROGRESSIVE COMPANIES 154
13.8.2 DYNAMIC COMPANIES 154
13.8.3 RESPONSIVE COMPANIES 154
13.8.4 STARTING BLOCKS 154
FIGURE 35 QUANTUM COMPUTING IN HEALTHCARE MARKET: COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES (2022) 155
13.9 COMPETITIVE SCENARIO 156
13.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS 156
TABLE 110 PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2020– APRIL 2023 156
13.9.2 DEALS 157
TABLE 111 DEALS, JANUARY 2020– APRIL 2023 157
14 COMPANY PROFILES 158
(Business overview, Products/Solutions/Services offered, Recent Developments, MNM view)*
14.1 KEY PLAYERS 158
14.1.1 RIGETTI & CO, LLC. 158
TABLE 112 RIGETTI & CO, LLC.: COMPANY OVERVIEW 158
FIGURE 36 RIGETTI & CO, LLC.: COMPANY SNAPSHOT (2022) 159
14.1.2 IBM 163
TABLE 113 IBM: COMPANY OVERVIEW 163
FIGURE 37 IBM: COMPANY SNAPSHOT (2022) 163
14.1.3 D-WAVE QUANTUM INC. 166
TABLE 114 D-WAVE QUANTUM INC.: COMPANY OVERVIEW 166
FIGURE 38 D-WAVE QUANTUM INC.: COMPANY SNAPSHOT (2022) 166
14.1.4 QUANDELA 171
TABLE 115 QUANDELA: COMPANY OVERVIEW 171
14.1.5 IONQ 174
TABLE 116 IONQ: COMPANY OVERVIEW 174
FIGURE 39 IONQ: COMPANY SNAPSHOT (2022) 174
14.1.6 QUANTINUUM LTD. 177
TABLE 117 QUANTINUUM LTD.: COMPANY OVERVIEW 177
14.1.7 GOOGLE LLC 179
TABLE 118 GOOGLE LLC: COMPANY OVERVIEW 179
FIGURE 40 GOOGLE LLC: COMPANY SNAPSHOT (2022) 180
14.1.8 ID QUANTIQUE 182
TABLE 119 ID QUANTIQUE: COMPANY OVERVIEW 182
14.1.9 ZAPATA COMPUTING 184
TABLE 120 ZAPATA COMPUTING: COMPANY OVERVIEW 184
14.1.10 ATOS SE 186
TABLE 121 ATOS SE: COMPANY OVERVIEW 186
FIGURE 41 ATOS SE: COMPANY SNAPSHOT (2022) 186
14.1.11 QC WARE 188
TABLE 122 QC WARE: COMPANY OVERVIEW 188
14.1.12 CLASSIQ TECHNOLOGIES LTD. 190
TABLE 123 CLASSIQ TECHNOLOGIES LTD.: COMPANY OVERVIEW 190
14.1.13 XANADU QUANTUM TECHNOLOGIES INC. 192
TABLE 124 XANADU QUANTUM TECHNOLOGIES INC.: COMPANY OVERVIEW 192
14.1.14 HEFEI ORIGIN QUANTUM COMPUTING TECHNOLOGY CO., LTD. 194
TABLE 125 HEFEI ORIGIN QUANTUM COMPUTING TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 194
14.1.15 PROTIVITI INC. 196
TABLE 126 PROTIVITI INC.: COMPANY OVERVIEW 196
14.1.16 PWC 197
TABLE 127 PWC: COMPANY OVERVIEW 197
14.1.17 DELOITTE 198
TABLE 128 DELOITTE: COMPANY OVERVIEW 198
14.1.18 ACCENTURE 199
TABLE 129 ACCENTURE: COMPANY OVERVIEW 199
FIGURE 42 ACCENTURE: COMPANY SNAPSHOT (2022) 200
14.2 OTHER PLAYERS 202
14.2.1 AMAZON WEB SERVICES (AWS) 202
14.2.2 PASQAL 203
14.2.3 FUJITSU 203
14.2.4 SANDBOX AQ 204
14.2.5 SEEQC 204
14.2.6 QUINTESSENCELABS 205
14.2.7 QNAMI 206
*Details on Business overview, Products/Solutions/Services offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
15 APPENDIX 207
15.1 DISCUSSION GUIDE 207
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 211
15.3 CUSTOMIZATION OPTIONS 213
15.4 RELATED REPORTS 214
15.5 AUTHOR DETAILS 215

　

ページTOPに戻る


　

Summary

The global quantum computing in healthcare market is projected to reach USD 503 million by 2028 from USD 85 million in 2023, at a high CAGR of 42.5% during the forecast period. The technological advancements in quantum computing supporting various healthcare applications will provide lucrative opportunities to the market during the forecast period.

“The cloud based segment registered the highest CAGR during the forecast period in healthcare market, by deployment ”
In 2022, the cloud-based segment accounted for a significant share of the quantum computing in healthcare market. The growth of the cloud-based segment can be attributed to the limited lifespan of rapidly advancing quantum computing systems, hassle-free scalability and flexibility, which in turn improves the ultimate decision-making process while using the quantum cloud services.

“Superconducting Qubits segment accounted for the largest share of the quantum computing in healthcare market, By Technology”
In 2022, the superconducting qubits segment accounted for the largest share of the quantum computing in healthcare market. The large share can be attributed to the fast gate speed of quantum computing systems based on superconducting qubits and the high degree of control possible with this type of qubit, making them flexible to be used for various applications such as drug discovery, imaging diagnostics, personalized medicine, etc.

“Pharmaceutical and Biopharmaceutical companies was the largest segment by end user of quantum computing in healthcare market in 2022”
In 2022, the pharmaceutical & biopharmaceutical companies segment accounted for a significant share of the quantum computing in healthcare market. The growth of the pharmaceutical & biopharmaceutical companies segment can be attributed to the ability of quantum computing to make R&D dramatically faster and more targeted and precise by making target identification, drug design, and toxicity testing less dependent on trial and error and therefore expedite complex drug discovery & development procedures, and enhanced accuracy. Its long-term benefits include the better utilization of resources and capital, better return on investment, and a substantial increase in the delivery of new medicines for chronic diseases.

“APAC to witness the highest growth rate during the forecast period.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Factors such as growing demand for advanced technologies such as quantum computing for research & genomics purposes, growing awareness and adoption of quantum computing in emerging regions, and improving healthcare infrastructure.
The break-down of primary participants is as mentioned below:
• By Company Type - Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
• By Designation - C-level: 42%, Director-level: 31%, and Others: 27%
• By Region - North America: 32%, Europe: 32%, Asia Pacific: 26%, Middle East & Africa: 5%, Latin America: 5%

Key Players in the Quantum Computing In Healthcare Market
The key players operating in the Quantum Computing in Healthcare Market include IBM (US), Google, Inc. (US), Rigetti & Co, LLC. (US), Quandela (France), D-Wave Quantum Inc. (Canada), Quantinuum, Ltd. (US & UK), ID Quantique (Switzerland), Zapata Computing (US), Atos SE (France), IonQ (US), Classiq Technologies, Inc. (US), Xanadu Quantum Technologies Inc. (Canada), QC Ware (California), Protiviti, Inc. (US), Hefei Origin Quantum Computing Technology Co., Ltd. (China), PwC (UK), Deloitte (UK), Accenture (Ireland), Amazon Web Services (US), Pasqal (France), Fujitsu (Japan), Sandbox AQ (US), SEEQC (US), Quintessence Labs (Australia), and Qnami (Switzerland).
Research Coverage:
The report analyzes the Quantum Computing in Healthcare Market and aims to estimate the market size and future growth potential of various market segments, based on components, deployment mode, application, technology, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
 Analysis of key drivers (increasing Investments in quantum computing in developed as well as emerging economies, growing inclination of payers toward quantum computing, rising demand for personalized medicine, increasing funding and investments in quantum computing startups), restraints (accuracy issues with quantum computing systems and high implementation costs), opportunities (technological advancements in quantum computing supporting various healthcare applications, potential applications in medical image analysis and oncology),and challenges (lack of technical expertise & data management issues) influencing the growth of the healthcare interoperability solutions market.
 Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the quantum computing in healthcare market.
 Market Development: Comprehensive information on the lucrative emerging markets, component, deployment mode, technology, application, end user, and region.
 Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the quantum computing in healthcare market
 Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the quantum computing in healthcare market like IBM (US), Google, Inc. (US), Rigetti & Co, LLC. (US), Quandela (France), D-Wave Quantum Inc. (Canada), Quantinuum, Ltd. (US & UK).



ページTOPに戻る


Table of Contents

1 INTRODUCTION 27
1.1 STUDY OBJECTIVES 27
1.2 MARKET DEFINITION 27
TABLE 1 INCLUSIONS & EXCLUSIONS 27
1.3 STUDY SCOPE 28
1.3.1 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY REGION 28
1.3.2 YEARS CONSIDERED 29
1.4 CURRENCY CONSIDERED 29
TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 29
1.5 STAKEHOLDERS 30
1.6 LIMITATIONS 30
1.7 IMPACT OF RECESSION 30
2 RESEARCH METHODOLOGY 31
2.1 RESEARCH APPROACH 31
FIGURE 1 RESEARCH DESIGN 31
2.1.1 SECONDARY RESEARCH 32
2.1.1.1 Key data from secondary sources 33
2.1.2 PRIMARY RESEARCH 33
2.1.2.1 Primary sources 34
2.1.2.2 Key data from primary sources 35
2.1.2.3 Breakdown of primaries 35
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 35
2.1.2.4 Insights from primary experts 36
2.2 MARKET SIZE ESTIMATION 36
FIGURE 3 BOTTOM-UP APPROACH 37
FIGURE 4 TOP-DOWN APPROACH 37
FIGURE 5 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF QUANTUM COMPUTING IN HEALTHCARE INDUSTRY 39
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 39
2.3 MARKET BREAKDOWN DATA TRIANGULATION 41
FIGURE 7 DATA TRIANGULATION METHODOLOGY 41
2.4 MARKET SHARE ESTIMATION 41
2.5 STUDY ASSUMPTIONS 42
2.6 RESEARCH LIMITATIONS 42
2.6.1 METHODOLOGY-RELATED LIMITATIONS 42
2.7 RISK ASSESSMENT 43
TABLE 3 RISK ASSESSMENT: QUANTUM COMPUTING IN HEALTHCARE MARKET 43
2.8 IMPACT OF RECESSION ON QUANTUM COMPUTING IN HEALTHCARE MARKET 43
3 EXECUTIVE SUMMARY 44
FIGURE 8 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023 VS. 2028 (USD MILLION) 44
FIGURE 9 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023 VS. 2028 (USD MILLION) 45
FIGURE 10 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 45
FIGURE 11 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 46
FIGURE 12 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 46
FIGURE 13 QUANTUM COMPUTING IN HEALTHCARE MARKET: REGIONAL SNAPSHOT 47
4 PREMIUM INSIGHTS 48
4.1 OVERVIEW OF QUANTUM COMPUTING IN HEALTHCARE MARKET 48
FIGURE 14 GOVERNMENT SUPPORT FOR ADOPTION OF QUANTUM COMPUTING TO DRIVE MARKET GROWTH 48
4.2 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT 49
FIGURE 15 HARDWARE SEGMENT AND JAPAN TO COMMAND LARGEST SHARES OF ASIA PACIFIC MARKET IN 2022 49
4.3 GEOGRAPHIC SNAPSHOT OF QUANTUM COMPUTING IN HEALTHCARE MARKET 50
FIGURE 16 MARKET IN CHINA TO GROW AT HIGHEST CAGR 50
4.4 REGIONAL MIX: QUANTUM COMPUTING IN HEALTHCARE MARKET 51
FIGURE 17 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
FIGURE 18 QUANTUM COMPUTING IN HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 52
TABLE 4 MARKET DYNAMICS: QUANTUM COMPUTING IN HEALTHCARE MARKET 53
5.2.1 MARKET DRIVERS 53
5.2.1.1 Increasing investments in quantum computing in developed as well as emerging economies 53
5.2.1.2 Growing inclination of payers toward quantum computing 54
5.2.1.3 Rising demand for personalized medicine 54
5.2.1.4 Increasing funding and investments in quantum computing startups 55
5.2.2 RESTRAINTS 56
5.2.2.1 Accuracy issues with quantum computing systems and high implementation costs 56
5.2.3 OPPORTUNITIES 56
5.2.3.1 Technological advancements in quantum computing supporting various healthcare applications 56
5.2.3.2 Potential applications in medical image analysis and oncology 57
5.2.4 CHALLENGES 57
5.2.4.1 Lack of technical expertise and data management issues 57
6 INDUSTRY INSIGHTS 58
6.1 INDUSTRY TRENDS 58
6.1.1 HYBRID QUANTUM-CLASSICAL COMPUTING 58
6.1.2 QUANTUM MACHINE LEARNING 59
6.1.3 GROWING NUMBER OF APPLICATIONS IN HEALTHCARE INDUSTRY 59
6.2 TECHNOLOGY ANALYSIS 60
6.2.1 QUANTUM ARTIFICIAL INTELLIGENCE 60
6.2.2 QUANTUM COMMUNICATION TECHNOLOGY 60
6.2.3 QUANTUM COMPUTING ACADEMIA 61
6.2.4 CYBERSECURITY TRANSFORMATION 61
6.2.5 QUANTUM SENSING 61
6.3 PORTER’S FIVE FORCES ANALYSIS 61
FIGURE 19 QUANTUM COMPUTING MARKET: PORTER’S FIVE FORCES ANALYSIS 62
6.4 REGULATORY ANALYSIS 62
6.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63
TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63
TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64
TABLE 8 ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64
6.4.2 REGULATORY STANDARDS 65
6.4.2.1 P1913 – Software-defined quantum communication 65
6.4.2.2 P7130 – Standard for quantum technologies definitions 65
6.4.2.3 P7131 – Standard for quantum computing performance metrics and benchmarking 65
6.5 VALUE CHAIN ANALYSIS 65
FIGURE 20 QUANTUM COMPUTING IN HEALTHCARE MARKET: VALUE CHAIN ANALYSIS 65
6.5.1 RESEARCH, DESIGN, AND DEVELOPMENT 66
6.5.2 MANUFACTURERS & SERVICE PROVIDERS 66
6.5.3 MARKETING & SALES EXECUTIVES 66
6.5.4 END USERS 66
6.6 ECOSYSTEM ANALYSIS 66
FIGURE 21 QUANTUM COMPUTING IN HEALTHCARE MARKET: ECOSYSTEM ANALYSIS 67
6.7 PATENT ANALYSIS 67
FIGURE 22 TOP PATENT OWNERS AND APPLICANTS FOR HEALTHCARE IT SOLUTIONS (JANUARY 2011–APRIL 2023) 68
FIGURE 23 PATENT ANALYSIS: QUANTUM COMPUTING IN HEALTHCARE MARKET (JANUARY 2015–APRIL 2023) 68
6.8 CASE STUDY ANALYSIS 69
TABLE 9 MENTEN AI LEVERAGED D-WAVE QUANTUM COMPUTING PRODUCTS TO BATTLE COVID-19 WITH QUANTUM PEPTIDE THERAPEUTICS 69
6.9 KEY STAKEHOLDERS AND BUYING CRITERIA 70
6.9.1 KEY STAKEHOLDERS ON BUYING PROCESS 70
FIGURE 24 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS 70
TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 70
6.9.2 BUYING CRITERIA 71
FIGURE 25 KEY BUYING CRITERIA FOR QUANTUM COMPUTING BY COMPONENTS 71
TABLE 11 KEY BUYING CRITERIA FOR QUANTUM COMPUTING BY COMPONENT 71
6.10 KEY CONFERENCES AND EVENTS (2023–2024) 72
6.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 73
FIGURE 26 REVENUE SHIFT IN QUANTUM COMPUTING IN HEALTHCARE MARKET 73
7 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT 74
7.1 INTRODUCTION 75
TABLE 12 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 75
7.2 SOFTWARE 75
7.2.1 SHIFT TO WEB/CLOUD-BASED MODELS TO SUPPORT GROWTH 75
TABLE 13 QUANTUM COMPUTING IN HEALTHCARE SOFTWARE OFFERED BY KEY MARKET PLAYERS 76
TABLE 14 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION) 76
7.3 HARDWARE 77
7.3.1 NEED FOR FREQUENT HARDWARE UPGRADES TO DRIVE MARKET GROWTH 77
TABLE 15 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION) 77
7.4 SERVICES 78
7.4.1 INTRODUCTION OF COMPLEX SOFTWARE TO DRIVE DEMAND FOR SERVICES 78
TABLE 16 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 79
8 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT 80
8.1 INTRODUCTION 81
TABLE 17 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 81
8.2 ON-PREMISES 81
8.2.1 RISING DEPLOYMENT OF ON-PREMISES QUANTUM COMPUTERS BY ORGANIZATIONS TO ENSURE DATA SECURITY 81
TABLE 18 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR ON-PREMISES SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION) 82
8.3 CLOUD-BASED 82
8.3.1 INCREASING PREFERENCE FOR CLOUD-BASED QUANTUM COMPUTING FOR RESEARCH & DEVELOPMENT USING DIFFERENT APPROACHES 82
TABLE 19 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR CLOUD-BASED SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION) 83
9 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY 84
9.1 INTRODUCTION 85
TABLE 20 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 85
9.2 SUPERCONDUCTING QUBITS 85
9.2.1 LOW POWER CONSUMPTION, HIGH SPEED, AND ABILITY TO OPERATE AT LOW TEMPERATURES TO DRIVE MARKET 85
TABLE 21 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR SUPERCONDUCTING QUBITS, BY COUNTRY, 2021–2028 (USD MILLION) 86
9.3 TRAPPED IONS 86
9.3.1 SUPERIOR CONNECTIVITY AND HIGHER GATE FIDELITY TO DRIVE MARKET 86
TABLE 22 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR TRAPPED IONS, BY COUNTRY, 2021–2028 (USD MILLION) 87
9.4 QUANTUM ANNEALING 87
9.4.1 QUICK DISCOVERY OF MOST EFFICIENT CONFIGURATIONS AMONG POSSIBLE COMBINATIONS OF VARIABLES TO DRIVE MARKET 87
TABLE 23 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR QUANTUM ANNEALING, BY COUNTRY, 2021–2028 (USD MILLION) 88
9.5 OTHERS 88
TABLE 24 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 89
10 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION 90
10.1 INTRODUCTION 91
TABLE 25 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 91
10.2 DRUG DISCOVERY & DEVELOPMENT 91
10.2.1 ENABLING ACCURATE DATA PROJECTIONS AND SOLUTIONS FOR DRUG DISCOVERY AND DEVELOPMENT TO BOOST MARKET GROWTH 91
TABLE 26 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 92
10.3 MEDICAL DIAGNOSTICS 92
10.3.1 PRECISE AND SENSITIVE MEDICAL DIAGNOSTICS PROCEDURES TO DRIVE MARKET 92
TABLE 27 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR MEDICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 93
10.4 GENOMICS & PRECISION MEDICINE 93
10.4.1 UNLOCKING POWER OF GENOMICS & PRECISION MEDICINE WITH QUANTUM COMPUTING TECHNOLOGY 93
TABLE 28 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR GENOMICS & PRECISION MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 94
10.5 RADIOTHERAPY 94
10.5.1 QUANTUM RADIOTHERAPY: ENABLING MORE PERSONALIZED AND PRECISE TREATMENT IN FIGHT AGAINST CANCER 94
TABLE 29 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR RADIOTHERAPY, BY COUNTRY, 2021–2028 (USD MILLION) 95
10.6 RISK ANALYSIS 96
10.6.1 ENHANCES PRICING MODEL MANAGEMENT AND DECREASE IN COSTS ASSOCIATED WITH FRAUD 96
TABLE 30 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR RISK ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION) 96
10.7 OTHERS (POPULATION HEALTH MANAGEMENT, SECURITY IN HEALTHCARE) 97
10.7.1 SECURELY TRANSFORMING POPULATION HEALTH WITH QUANTUM COMPUTING 97
TABLE 31 QUANTUM COMPUTING IN HEALTHCARE MARKET OTHER APPLICATIONS (POPULATION HEALTH MANAGEMENT, SECURITY IN HEALTHCARE), BY COUNTRY, 2021–2028 (USD MILLION) 97
11 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY END USER 98
11.1 INTRODUCTION 99
TABLE 32 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 99
11.2 PHARMA & BIOPHARMA COMPANIES 99
11.2.1 RISING DEMAND FOR SOLUTIONS TO REDUCE TIME AND COSTS OF DRUG DEVELOPMENT 99
TABLE 33 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR PHARMA & BIOPHARMA COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 100
11.3 LABS & RESEARCH INSTITUTES 100
11.3.1 INCREASED RESEARCH ACTIVITIES TO ENCOURAGE USE OF AI IN GENOMICS IN ACADEMIC AND GOVERNMENT INSTITUTES 100
TABLE 34 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR LABS & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 101
11.4 HEALTHCARE PROVIDERS 101
11.4.1 HIGH NUMBER OF BENEFITS TO IMPROVE PATIENT MANAGEMENT, LOWER COSTS, AND DELIVER BETTER PATIENT TREATMENT 101
TABLE 35 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 102
11.5 HEALTHCARE PAYERS 102
11.5.1 POTENTIAL TO REDUCE READMISSIONS AND OVERHEAD COSTS TO DRIVE ADOPTION 102
TABLE 36 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 103
12 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY REGION 104
12.1 INTRODUCTION 105
TABLE 37 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY REGION, 2021–2028 (USD MILLION) 105
12.2 NORTH AMERICA 105
FIGURE 27 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET SNAPSHOT, 2022 106
TABLE 38 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 39 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 107
TABLE 40 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 107
TABLE 41 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 107
TABLE 42 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 108
TABLE 43 NORTH AMERICA: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 108
12.2.1 US 109
12.2.1.1 Expanding applications of quantum computing in healthcare to bolster market growth 109
TABLE 44 US: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 109
TABLE 45 US: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 109
TABLE 46 US: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 110
TABLE 47 US: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 110
TABLE 48 US: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 111
12.2.2 CANADA 111
12.2.2.1 Investments and developments in quantum computing industry to drive market 111
TABLE 49 CANADA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 112
TABLE 50 CANADA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 112
TABLE 51 CANADA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 112
TABLE 52 CANADA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 113
TABLE 53 CANADA: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 113
12.3 EUROPE 114
TABLE 54 EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 55 EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 115
TABLE 56 EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 115
TABLE 57 EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 115
TABLE 58 EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 116
TABLE 59 EUROPE: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 116
12.3.1 GERMANY 117
12.3.1.1 Collaborations & partnerships to drive adoption of quantum computing solutions 117
TABLE 60 GERMANY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 117
TABLE 61 GERMANY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 118
TABLE 62 GERMANY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 118
TABLE 63 GERMANY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 119
TABLE 64 GERMANY: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 119
12.3.2 UK 120
12.3.2.1 Increased focus on quantum computing applications to support growth 120
TABLE 65 UK: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 120
TABLE 66 UK: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 121
TABLE 67 UK: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 121
TABLE 68 UK: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 122
TABLE 69 UK: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 122
12.3.3 FRANCE 122
12.3.3.1 Government funding for quantum computing to bolster growth 122
TABLE 70 FRANCE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 123
TABLE 71 FRANCE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 123
TABLE 72 FRANCE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 124
TABLE 73 FRANCE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 124
TABLE 74 FRANCE: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 125
12.3.4 REST OF EUROPE 125
TABLE 75 REST OF EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 126
TABLE 76 REST OF EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 126
TABLE 77 REST OF EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 126
TABLE 78 REST OF EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 127
TABLE 79 REST OF EUROPE: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 127
12.4 ASIA PACIFIC 128
FIGURE 28 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE SNAPSHOT 129
TABLE 80 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 81 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 130
TABLE 82 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 130
TABLE 83 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 130
TABLE 84 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 131
TABLE 85 ASIA PACIFIC: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 131
12.4.1 JAPAN 132
12.4.1.1 Rising penetration of technologies to support market growth 132
TABLE 86 JAPAN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 132
TABLE 87 JAPAN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 133
TABLE 88 JAPAN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 133
TABLE 89 JAPAN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 134
TABLE 90 JAPAN: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 134
12.4.2 CHINA 134
12.4.2.1 Dominating healthcare market in Asia Pacific 134
TABLE 91 CHINA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 135
TABLE 92 CHINA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 135
TABLE 93 CHINA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 136
TABLE 94 CHINA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 136
TABLE 95 CHINA: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 137
12.4.3 REST OF ASIA PACIFIC 137
TABLE 96 REST OF ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 138
TABLE 97 REST OF ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 138
TABLE 98 REST OF ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 138
TABLE 99 REST OF ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 139
TABLE 100 REST OF ASIA PACIFIC: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 139
12.5 REST OF THE WORLD 140
TABLE 101 REST OF THE WORLD: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 140
TABLE 102 REST OF THE WORLD: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION) 141
TABLE 103 REST OF THE WORLD: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 141
TABLE 104 REST OF THE WORLD: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 142
TABLE 105 REST OF THE WORLD: QUANTUM COMPUTING IN MARKET, BY END USER, 2021–2028 (USD MILLION) 142
13 COMPETITIVE LANDSCAPE 143
13.1 OVERVIEW 143
FIGURE 29 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2020 AND APRIL 2023 144
13.2 MARKET RANKING ANALYSIS 145
FIGURE 30 QUANTUM COMPUTING IN HEALTHCARE MARKET RANKING ANALYSIS, BY PLAYER, 2022 145
13.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 146
FIGURE 31 QUANTUM COMPUTING IN HEALTHCARE MARKET: REVENUE ANALYSIS OF KEY PLAYERS 146
13.4 QUANTUM COMPUTING IN HEALTHCARE MARKET: R&D EXPENDITURE 146
FIGURE 32 R&D EXPENDITURE OF KEY PLAYERS (2021 VS. 2022) 146
13.5 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 147
FIGURE 33 QUANTUM COMPUTING IN HEALTHCARE MARKET: GEOGRAPHIC REVENUE MIX 147
13.6 COMPETITIVE BENCHMARKING 148
TABLE 106 FOOTPRINTS OF COMPANIES IN QUANTUM COMPUTING IN HEALTHCARE MARKET 148
TABLE 107 COMPANY PRODUCT FOOTPRINT (26 COMPANIES) 149
TABLE 108 COMPANY APPLICATION FOOTPRINT (16 COMPANIES) 150
TABLE 109 COMPANY REGION FOOTPRINT (25 COMPANIES) 151
13.7 COMPANY EVALUATION QUADRANT 152
13.7.1 STARS 152
13.7.2 EMERGING LEADERS 152
13.7.3 PERVASIVE PLAYERS 152
13.7.4 PARTICIPANTS 153
FIGURE 34 QUANTUM COMPUTING IN HEALTHCARE MARKET: COMPANY EVALUATION QUADRANT (2022) 153
13.8 COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES 154
13.8.1 PROGRESSIVE COMPANIES 154
13.8.2 DYNAMIC COMPANIES 154
13.8.3 RESPONSIVE COMPANIES 154
13.8.4 STARTING BLOCKS 154
FIGURE 35 QUANTUM COMPUTING IN HEALTHCARE MARKET: COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES (2022) 155
13.9 COMPETITIVE SCENARIO 156
13.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS 156
TABLE 110 PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2020– APRIL 2023 156
13.9.2 DEALS 157
TABLE 111 DEALS, JANUARY 2020– APRIL 2023 157
14 COMPANY PROFILES 158
(Business overview, Products/Solutions/Services offered, Recent Developments, MNM view)*
14.1 KEY PLAYERS 158
14.1.1 RIGETTI & CO, LLC. 158
TABLE 112 RIGETTI & CO, LLC.: COMPANY OVERVIEW 158
FIGURE 36 RIGETTI & CO, LLC.: COMPANY SNAPSHOT (2022) 159
14.1.2 IBM 163
TABLE 113 IBM: COMPANY OVERVIEW 163
FIGURE 37 IBM: COMPANY SNAPSHOT (2022) 163
14.1.3 D-WAVE QUANTUM INC. 166
TABLE 114 D-WAVE QUANTUM INC.: COMPANY OVERVIEW 166
FIGURE 38 D-WAVE QUANTUM INC.: COMPANY SNAPSHOT (2022) 166
14.1.4 QUANDELA 171
TABLE 115 QUANDELA: COMPANY OVERVIEW 171
14.1.5 IONQ 174
TABLE 116 IONQ: COMPANY OVERVIEW 174
FIGURE 39 IONQ: COMPANY SNAPSHOT (2022) 174
14.1.6 QUANTINUUM LTD. 177
TABLE 117 QUANTINUUM LTD.: COMPANY OVERVIEW 177
14.1.7 GOOGLE LLC 179
TABLE 118 GOOGLE LLC: COMPANY OVERVIEW 179
FIGURE 40 GOOGLE LLC: COMPANY SNAPSHOT (2022) 180
14.1.8 ID QUANTIQUE 182
TABLE 119 ID QUANTIQUE: COMPANY OVERVIEW 182
14.1.9 ZAPATA COMPUTING 184
TABLE 120 ZAPATA COMPUTING: COMPANY OVERVIEW 184
14.1.10 ATOS SE 186
TABLE 121 ATOS SE: COMPANY OVERVIEW 186
FIGURE 41 ATOS SE: COMPANY SNAPSHOT (2022) 186
14.1.11 QC WARE 188
TABLE 122 QC WARE: COMPANY OVERVIEW 188
14.1.12 CLASSIQ TECHNOLOGIES LTD. 190
TABLE 123 CLASSIQ TECHNOLOGIES LTD.: COMPANY OVERVIEW 190
14.1.13 XANADU QUANTUM TECHNOLOGIES INC. 192
TABLE 124 XANADU QUANTUM TECHNOLOGIES INC.: COMPANY OVERVIEW 192
14.1.14 HEFEI ORIGIN QUANTUM COMPUTING TECHNOLOGY CO., LTD. 194
TABLE 125 HEFEI ORIGIN QUANTUM COMPUTING TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 194
14.1.15 PROTIVITI INC. 196
TABLE 126 PROTIVITI INC.: COMPANY OVERVIEW 196
14.1.16 PWC 197
TABLE 127 PWC: COMPANY OVERVIEW 197
14.1.17 DELOITTE 198
TABLE 128 DELOITTE: COMPANY OVERVIEW 198
14.1.18 ACCENTURE 199
TABLE 129 ACCENTURE: COMPANY OVERVIEW 199
FIGURE 42 ACCENTURE: COMPANY SNAPSHOT (2022) 200
14.2 OTHER PLAYERS 202
14.2.1 AMAZON WEB SERVICES (AWS) 202
14.2.2 PASQAL 203
14.2.3 FUJITSU 203
14.2.4 SANDBOX AQ 204
14.2.5 SEEQC 204
14.2.6 QUINTESSENCELABS 205
14.2.7 QNAMI 206
*Details on Business overview, Products/Solutions/Services offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
15 APPENDIX 207
15.1 DISCUSSION GUIDE 207
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 211
15.3 CUSTOMIZATION OPTIONS 213
15.4 RELATED REPORTS 214
15.5 AUTHOR DETAILS 215

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

MarketsandMarkets社のHealthcare IT分野での最新刊レポート

本レポートと同じKEY WORD（drug）の最新刊レポート


よくあるご質問


MarketsandMarkets社はどのような調査会社ですか?


マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15　10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.